Fox Run Management, L.L.C. Guardant Health, Inc. Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
A detailed history of Fox Run Management, L.L.C. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 12,084 shares of GH stock, worth $553,930. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,084Holding current value
$553,930% of portfolio
0.07%Shares
13 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
115MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$552 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$515 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$294 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$250 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$239 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.69B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...